NanoVibronix, Inc.
NAOV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 12% | 203.6% | -55.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 59% | 67.3% | 22.2% | 45.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -144.1% | -155.3% | -719.7% | -840.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -144.8% | -162.5% | -724.5% | -842.6% |
| EPS Diluted | -13.73 | -21.2 | -38.4 | -113.5 |
| % Growth | 35.2% | 44.8% | 66.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |